Literature DB >> 23040075

Post-cardiac injury syndromes. An emerging cause of pericardial diseases.

Massimo Imazio1, Brian D Hoit.   

Abstract

The term "post-cardiac injury syndromes" includes post-myocardial infarction pericarditis, post-pericardiotomy syndrome, and post-traumatic pericarditis (iatrogenic, i.e. after percutaneous coronary or intracardiac interventions, such as pacemaker lead insertion, radiofrequency ablation, or non-iatrogenic, i.e. following blunt or penetrating trauma). All these conditions represent different clinical conditions characterized by an initial cardiac injury involving the pericardium/myocardium and/or pleura and the subsequent inflammatory syndrome ranging from simple, uncomplicated pericarditis to more complicated cases with pleuropericarditis, cardiac tamponade or massive pleural effusion. The etiopathogenesis is presumed to be immune-mediated in predisposed individuals that develop autoreactive reactions following the initial traumatic event. Treatment is essentially based on empirical anti-inflammatory therapy and adjunctive colchicine, which has been shown to be safe and efficacious for the prevention of pericarditis.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Pericarditis; Post-cardiac injury syndrome; Post-pericardial injury syndrome; Post-pericardiotomy syndrome

Mesh:

Year:  2012        PMID: 23040075     DOI: 10.1016/j.ijcard.2012.09.052

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  48 in total

1.  The return of a disappearing entity: Dressler's syndrome after transvenous pacemaker implantation.

Authors:  António Tralhão; Diogo Cavaco; Marisa Trabulo; António M Ferreira
Journal:  BMJ Case Rep       Date:  2014-03-20

2.  Spontaneous hemothorax resulting from tissue plasminogen activator in a patient with ischemic stroke and unrecognized recent myocardial infarction.

Authors:  Daniel A Kelmenson; Jonathan S Kurche; Mark Geraci
Journal:  Ann Am Thorac Soc       Date:  2015-07

3.  Successful use of anakinra for colchicine-intolerant, corticosteroid-dependent recurrent pericarditis secondary to postcardiac injury syndrome after pacemaker placement.

Authors:  Muhammad Hamza Saad Shaukat; Muhammad Asim Shabbir; Sulagna Mookherjee; Ruben Peredo-Wende
Journal:  BMJ Case Rep       Date:  2019-04-04

Review 4.  Post cardiac injury syndrome after initially uncomplicated CRT-D implantation: a case report and a systematic review.

Authors:  Farbod Sedaghat-Hamedani; Edgar Zitron; Elham Kayvanpour; Hanns-Martin Lorenz; Hugo A Katus; Benjamin Meder
Journal:  Clin Res Cardiol       Date:  2014-04-29       Impact factor: 5.460

5.  Does Prophylactic Ibuprofen After Surgical Atrial Septal Defect Repair Decrease the Rate of Post-Pericardiotomy Syndrome?

Authors:  Edon J Rabinowitz; David B Meyer; Priya Kholwadwala; Nina Kohn; Adnan Bakar
Journal:  Pediatr Cardiol       Date:  2018-06-14       Impact factor: 1.655

Review 6.  New Insights into Pericarditis: Mechanisms of Injury and Therapeutic Targets.

Authors:  Bo Xu; Serge C Harb; Paul C Cremer
Journal:  Curr Cardiol Rep       Date:  2017-07       Impact factor: 2.931

Review 7.  Hemopericardium in the acute clinical setting: Are we ready for a tailored management approach on the basis of MDCT findings?

Authors:  Tullio Valente; Maria Pignatiello; Giacomo Sica; Giorgio Bocchini; Gaetano Rea; Salvatore Cappabianca; Mariano Scaglione
Journal:  Radiol Med       Date:  2020-11-02       Impact factor: 3.469

8.  Postpericardiotomy syndrome after cardiac surgery.

Authors:  Joonas Lehto; Tuomas Kiviniemi
Journal:  Ann Med       Date:  2020-05-02       Impact factor: 4.709

Review 9.  Post-pericardiotomy Syndrome.

Authors:  Balaji K Tamarappoo; Allan L Klein
Journal:  Curr Cardiol Rep       Date:  2016-11       Impact factor: 2.931

Review 10.  Recurrent pericarditis: new and emerging therapeutic options.

Authors:  Massimo Imazio; George Lazaros; Antonio Brucato; Fiorenzo Gaita
Journal:  Nat Rev Cardiol       Date:  2015-08-11       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.